Share
Global Muscle Relaxant Drugs Market: Market Segments: By Product(Facial Muscle Relaxants, Skeletal muscle Relaxants, and Neuromuscular Blocking Agents);By Application (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy);and Region - Analysis of Market Size, Share & Trends for 2014 - 2019 and Forecasts to 2030
A muscle relaxant is a drug that affects the function of the skeletal muscle and reduces the tone of the muscle. They may be recent, such as muscle spasms, discomfort, and hyperreflexia, to relieve symptoms. In addition, the use of muscle relaxant drugs by pregnant women, the elderly and other opioid or alcohol addicts is highly limited. In tandem with general anesthetics, muscle relaxant medications are mainly used to achieve muscle relaxation during surgical procedures. In comparison, muscle spasms and spastic neurological disorders secondary to multiple sclerosis, cerebral palsy, fibromyalgia, myofascial pain syndrome, etc. are also included in the care. By inhibiting nerve impulses in the brain and spinal cord, these medications exert their muscle-relaxing effects and can help break the pain-spasm-pain loop, where pain causes the muscles to spasm as a defensive response and, in turn, causes more pain. They can also be used when their back pain causes disrupted sleep for their sedative effect.
The competitive factors driving the growth of the global demand for muscle relaxant drugs are expected to be the rising prevalence of musculoskeletal problems and increasing customer awareness of their treatment and management. Market development is attributed to numerous factors, such as the rising prevalence of skin diseases and the adverse effects of ultraviolet radiation, an increase in the use of neuromuscular blocking agents in surgery, an increase in the geriatric population, and an increase in disposable income, contributing to an increase in spending on facial aesthetic therapies. In addition, changing prescribing practices may change the growth rate of the demand for muscle relaxant drugs.
Global Muscle Relaxant DrugsMarket is segmented by product into facial aesthetics relaxants, neuromuscular blocking agents, and skeletal muscle relaxants.The greater market share of 50% in 2018 was accounted for by the facial aesthetics relaxants segment and is expected to see the highest growth during the forecast period, primarily due to the high safety and efficiency of these relaxants.The relaxant drugs for facial aesthetics are further categorized into botox, Dysport, and others. Among these, during the historical era, botox accounted for the greatest share of the demand for muscle relaxant drugs and is further expected to remain the top drug on the market during the forecast period. However, due to the growing number of facial and cosmetic surgeries and the evolving definition of beauty around the world, the segment of facial aesthetic relaxants is expected to experience the highest growth rate. Increased use during general surgeries of neuromuscular blocking agents will drive the growth of the global demand for muscle relaxant drugs.
Global Muscle Relaxant Drugs Market is segmented by application into hospitals pharmacy, online pharmacy, and retail pharmacy. Recently, due to the rising awareness of new disease reversal treatment options, there has been a tremendous change in patients choosing prescription medications over over-the-counter drugs. Due to the growing amount of hospital and clinical consultations, the hospital pharmacy would dominate the market.
The competitive factors driving the growth of the global demand for muscle relaxant drugs are expected to be the rising prevalence of musculoskeletal problems and increasing customer awareness of their treatment and management. Structurally distinct medications are the recent technologically improved muscle relaxants used to alleviate muscle spasms, discomfort, and hyperreflexia. Another main factor driving the growth of the muscle relaxant drug market is the rise in disposable income, which further contributes to an increase in spending on facial aesthetic therapies. In addition to the increase in disposable income, awareness of personal skincare is increasing worldwide.
The growing prevalence of skin diseases and adverse effects of ultraviolet radiation, growing disposable income leading to increased expenditure on facial aesthetics therapy, increasing geriatric population, and increasing usage of neuromuscular blocking agents in surgeries are the main factors driving the growth of the muscle relaxant drug market. The elasticity of the skin decreases and it becomes vulnerable to sunburn due to rising pollution, excessive consumption of alcohol and tobacco, and ultraviolet radiation. In addition, the majority of the world's population is affected by acne, the most common dermatological disease. Muscle relaxant procedures based on botulinum toxin are used to treat these skin diseases, contributing to the growth of the market for muscle relaxant drugs.
The growth of the muscle relaxant drug market is obstructed by factors such as strict regulatory requirements, risks associated with muscle relaxants, and high capital spending. Elevated capital is required to manufacture muscle relaxant drugs. In addition, as a complex process, the use, separation, and development of raw materials for the development of pharmaceutical and biopharmaceutical drugs require professional and qualified personnel. In addition, time-consuming procedures are the growth and approval of muscle relaxant medications. All these factors contribute to high spending on capital, which hinders the growth of the demand for muscle relaxant drugs.
Global Muscle Relaxant DrugsMarket is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, APAC and MENA.
Global Muscle Relaxant DrugsMarket in North America held the largest market share of XX.X% in the year 2018 and the region is expected to remain the largest during the next five years and is likely to remain dominant over the forecast time period. The increasing number of new drug applications in North America and the regional presence of a large number of renowned firms can be attributed to this regional supremacy. Europe took second place in the muscle relaxant drug market. Due to the rising aging population base in countries such as Japan, the Asia Pacific is projected to register a high CAGR in the muscle relaxant drugs market globally over the forecast period. Factors such as the increasing geriatric population and the increasing number of surgeries are expected to help the growth of the demand for muscle relaxant drugs in the Asia Pacific region.
Global Muscle Relaxant Drugs market, which is highly competitive, consists of several major players such as Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., which hold a substantial market share in the Global Muscle Relaxant Drugs market. Other players analyzed in this report are Medtronic, Mallinckrodt, Vertical Pharmaceuticals, Abbott Laboratories, Par Sterile Products, SteriMax, and Endo Pharmaceuticals. among others
Recently, various developments have been taking place in the market. For instance, GlaxoSmithKline PLC commenced building a large tablet manufacturing plant in Bengal, Karnataka, India in September 2015.
Global Muscle Relaxant Drugs Market Segments:
Market Segmentation
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT
Working with Fatpos Global, allowed us to take advantage of their knowledge and easy approach, allowing us to collect important data utilizing a variety of techniques. The results were clearly presented and explained, and FG responded to our questions with speed and expertise.
|
Swiss-based global building materials manufacturer |
The analyses and presentations Fatpos Global have produced for us have been of a very high caliber and have allowed us to proactively improve our customer relationship management. They have also done so while maintaining complete anonymity. Without any doubt, we suggest Fatpos Global to you.
|
|
Tech-powered construction company |
We appreciate the team’s punctuality, flexibility in terms of report modification, post report purchase support and pleasant reaction all around. Overall, my experience with this company was nothing but positive, and I couldn't be more grateful for their excellent service. Thank you for all that you do!
|
|
American global management consulting firm |
We are able to concentrate on the topics and implications that are most important to our clients thanks to the adaptability and responsiveness of the team at Fatpos Global. We would highly recommend this company to anyone in need of their services, and I will certainly be using them again in the future.
|
|
Headquartered in Zug, Switzerland, leading supplier of medical and surgical instrument |
To better study our client demographics, develop the ideal product-price architecture, and enhance our target marketing initiatives, we hired Fatpos Global. Every component of the project was completed, and we are very happy with the useful insights and actionable results.
|
|
Kosovan company, A leading organic fertilizers producer |
Thank you for your team's generous assistance, The final report was delivered to me, and I find it to be really helpful. Also, you may be sure that I will get in touch with you if I ever require fresh materials for market research. Gratitude once more.
|
|
German specialty chemicals company based in Cologne, Germany |
